catechin has been researched along with Radiodermatitis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| He, D; Kong, L; Li, X; Meng, X; Xing, L; Yu, J; Zhang, S; Zhao, H; Zhao, X; Zheng, M; Zhou, Z; Zhu, W | 1 |
| Jia, L; Li, X; Meng, X; Wang, X; Xie, J; Xie, P; Xing, L; Yin, X; Zhao, H; Zhu, W | 1 |
| Bonucci, M; Fioranelli, M; Lotti, T; Roccia, MG | 1 |
| Chen, G; Jia, L; Kong, L; Li, X; Meng, X; Sun, X; Xing, L; Yu, J; Zhao, H; Zhao, X; Zhu, W | 1 |
| Chen, G; Jia, L; Meng, X; Sun, X; Xing, L; Yu, J; Zhao, H; Zhao, X; Zheng, M; Zhu, W | 1 |
| Jeon, HY; Kim, JK; Kim, WG; Lee, SJ | 1 |
| Afaq, F; Katiyar, SK; Mukhtar, H; Perez, A | 1 |
4 trial(s) available for catechin and Radiodermatitis
| Article | Year |
|---|---|
Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy: A Double-Blind, Placebo-Controlled, Phase 2 Randomized Clinical Trial.
Topics: Breast Neoplasms; Catechin; Female; Humans; Middle Aged; Radiodermatitis; Treatment Outcome | 2022 |
Efficacy and safety of epigallocatechin-3-gallate in treatment acute severe dermatitis in patients with cancer receiving radiotherapy: a phase I clinical trial.
Topics: Acute Disease; Catechin; Dermatitis; Humans; Neoplasms; Radiodermatitis | 2023 |
Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.
Topics: Administration, Topical; Adult; Antioxidants; Breast Neoplasms; Catechin; Combined Modality Therapy; Female; Humans; Mastectomy; Middle Aged; Radiodermatitis; Radiotherapy, Adjuvant; Treatment Outcome | 2016 |
Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapy.
Topics: Administration, Cutaneous; Adult; Breast; Breast Neoplasms; Catechin; Female; Humans; Mastectomy; Middle Aged; Pain; Pain Management; Prospective Studies; Radiation-Protective Agents; Radiodermatitis; Radiotherapy, Adjuvant; Treatment Outcome; Young Adult | 2016 |
3 other study(ies) available for catechin and Radiodermatitis
| Article | Year |
|---|---|
Possible use of epigallocatechin-3-gallate (EGCG) as prevention of radio dermatitis in radiotherapy treated breast cancer patients.
Topics: Antioxidants; Breast Neoplasms; Catechin; Female; Humans; Radiodermatitis; Treatment Outcome | 2017 |
Effects of oral epigallocatechin gallate supplementation on the minimal erythema dose and UV-induced skin damage.
Topics: Administration, Oral; Animals; Antioxidants; Catechin; Dose-Response Relationship, Radiation; Erythema; Female; Radiation-Protective Agents; Radiodermatitis; Rats; Rats, Hairless; Tea; Ultraviolet Rays; Water Loss, Insensible | 2009 |
Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress.
Topics: Adult; Catalase; Catechin; Female; Free Radical Scavengers; Glutathione; Glutathione Peroxidase; Humans; Hydrogen Peroxide; Immunoenzyme Techniques; Leukocytes; Lipid Peroxidation; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Radiodermatitis; Skin; Tea; Time Factors; Ultraviolet Rays | 2001 |